Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Rituximab on Magnetic Resonance Imaging Evidence of Synovitis and Bone Lesions in Patients With Moderate or Severe Rheumatoid Arthritis

NCT00425932 is registered in ClinicalTrials.gov with Gaylis, Norman B., M.D. as lead sponsor.

NCT NCT00425932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00425932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Rituximab on Magnetic Resonance Imaging Evidence of Synovitis and Bone Lesions in Patients With Moderate or Severe Rheumatoid Arthritis
Lead sponsor
Gaylis, Norman B., M.D.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
November 30, 2012
Enrollment
60 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis